Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.2.3.15NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.6.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.1.35NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.45NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.31NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.39.1.2 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.4.15 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.75.10NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.36.21NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.1.23NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.134NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.39.1.3 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BN.1.3.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
C.38NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.1.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBC.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
Q.2 (Alpha)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BL.1.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
M.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
C.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.82 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
A.30NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.36.35NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.23.1 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.466.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.28 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.272NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.371NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AA.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.353NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.407NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AA.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.160.13NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.47NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.182NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.218NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.12.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
A.11NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.22 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.36.33NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.405NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.296NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.412NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AC.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
C.27NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.421NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.364NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.82NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.61NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.47NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used